3-16271709-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_138381.5(OXNAD1):​c.170T>G​(p.Val57Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000343 in 1,455,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

OXNAD1
NM_138381.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.393

Publications

0 publications found
Variant links:
Genes affected
OXNAD1 (HGNC:25128): (oxidoreductase NAD binding domain containing 1) Predicted to enable oxidoreductase activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06955257).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OXNAD1NM_138381.5 linkc.170T>G p.Val57Gly missense_variant Exon 4 of 9 ENST00000285083.10 NP_612390.1 Q96HP4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OXNAD1ENST00000285083.10 linkc.170T>G p.Val57Gly missense_variant Exon 4 of 9 1 NM_138381.5 ENSP00000285083.5 Q96HP4

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000343
AC:
5
AN:
1455728
Hom.:
0
Cov.:
30
AF XY:
0.00000552
AC XY:
4
AN XY:
724098
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32952
American (AMR)
AF:
0.00
AC:
0
AN:
42902
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25960
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39474
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84784
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53320
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5734
European-Non Finnish (NFE)
AF:
0.00000450
AC:
5
AN:
1110498
Other (OTH)
AF:
0.00
AC:
0
AN:
60104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 07, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.170T>G (p.V57G) alteration is located in exon 4 (coding exon 2) of the OXNAD1 gene. This alteration results from a T to G substitution at nucleotide position 170, causing the valine (V) at amino acid position 57 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
13
DANN
Benign
0.82
DEOGEN2
Benign
0.014
T;T;T;T;.
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.072
N
LIST_S2
Benign
0.69
T;.;T;.;T
M_CAP
Benign
0.0067
T
MetaRNN
Benign
0.070
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
.;L;L;.;.
PhyloP100
0.39
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.77
.;N;.;.;.
REVEL
Benign
0.045
Sift
Benign
0.37
.;T;.;.;.
Sift4G
Benign
0.38
T;T;T;T;T
Polyphen
0.11
.;B;B;.;.
Vest4
0.22
MutPred
0.34
.;Gain of glycosylation at S56 (P = 0.0283);Gain of glycosylation at S56 (P = 0.0283);.;Gain of glycosylation at S56 (P = 0.0283);
MVP
0.16
MPC
0.045
ClinPred
0.068
T
GERP RS
0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.045
gMVP
0.51
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr3-16313216; API